(Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
Sales | 12,050 | 0 | 350 | 0 | 0 |
Sales Growth | unch | -100.00% | unch | unch | -100.00% |
Net Income | -3,590 | -29,140 | -28,670 | -16,780 | -22,670 |
Net Income Growth | +87.68% | -1.64% | -70.86% | +25.98% | +35.15% |
Tracon Pharmaceuticals Inc (TCON)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0322 -0.0113 (-25.98%) 12/02/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0322 unch (unch) -
for Mon, Dec 2nd, 2024
TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California.
Fiscal Year End Date: 12/31